INNV vs OGN · rev $853.7M vs P/E 3.4, rev $3.02B
InnovAge Holding Corp (INNV) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
InnovAge Holding Corp (INNV) is a medical care facilities company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported INNV revenue for 2025-06-30 was $853.7M. Net income was -$35.3M. INNV currently screens at market cap $990.9M.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
INNV currently screens at market cap $990.9M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the INNV and OGN stock pages for the full models.
Not investment advice.